Honeycomb: Evaluation of Radiprodil in Children with GRIN-related Disorder
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Panzara, MD, MPH
Chief Medical Officer
Study Chair - Vijay Rai, PhD
Associate Director of Clinical Operations
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queensland Children'S Hospital
South Brisbane, Queensland, Australia
- the Hospital for Sick Children (sick Kids)
Toronto, Ontario, Canada
- Bc Children'S Hospital
Vancouver, Canada
- Abteilung Für Neuropädiatrie, Klinik Und Poliklinik Für Kinder - Und Jugendmedizin, Universitätsklinikum Leipzig
Leipzig, Germany
- Kbo-Kinderzentrum München Gemeinnützige Gmbh
München, Germany
- Istituto Di Ricovero E Cura A Carattere Scientifico (irccs) - Ospedale Pediatrico Bambino Gesu
Rome, Lazio, Italy
- Azienda Ospedaliero Universitaria Careggi (aouc) Firenze - Azienda Ospedaliera Universitaria Meyer
Florence, Tuscany, Italy
- Erasmus Medisch Centrum, Developmental & Genetic Pediatrics
Rotterdam, Netherlands
- Umc Utrecht - Wilhelmina Kinderziekenhuis, Polikliniek Kinderneurologie
Utrecht, Netherlands
- Universitat de Barcelona - Hospital Sant Joan de Deu Barcelona (hsjdb)
Barcelona, Spain
- Hospital Ruber Internacional
Madrid, Spain
- Royal Hospital for Children Glasgow
Glasgow, United Kingdom
- Great Ormond Street Hospital for Children Nhs Foundation Trust
London, United Kingdom
- Mid-Atlantic Epilepsy and Sleep Center
Bethesda, Maryland, United States
- Columbia University Irving Medical Center, Dept of Neurology
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Mar 2023
- Primary completion
- 30 Nov 2026
- Completion
- 30 Nov 2026
- Last update posted
- 15 Nov 2024
- Registered enrollment
- 24
- Registry id
- NCT05818943
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.